SAB5200019

Monoclonal Anti-DUX4 antibody produced in mouse

clone P2B1, 1 mg/mL, purified immunoglobulin

• Synonym(e): Anti-DUX10, Anti-DUX4, P2B1, Anti-double homeobox 4
• UNSPSC-Code: 12352203
• NACRES: NA.41

Eigenschaften

• Biologische Quelle: mouse
• Konjugat: unconjugated
• Antikörperform: purified immunoglobulin
• Antikörper-Produkttyp: primary antibodies
• Klon: P2B1, monoclonal
• Form: buffered aqueous glycerol solution
• Speziesreaktivität: human
• Konzentration: 1 mg/mL
• Methode(n): immunohistochemistry: suitable; indirect immunofluorescence: suitable; western blot: suitable
• Isotyp: IgG1
• NCBI-Hinterlegungsnummer: NP_149418.3
• UniProt-Hinterlegungsnummer: Q9UBX2
• Versandbedingung: wet ice
• Lagertemp.: −20°C
• Posttranslationale Modifikation Target: unmodified
• Angaben zum Gen: human ... DUX4(22947)

Beschreibung

Allgemeine Beschreibung

DUX4 (double homeobox 4) has been mapped to human chromosome 4q35.2. DUX4 is an open reading frame of tandem array D4Z4. It consists of two homeobox sequences.

Spezifität

This antibody recognizes human DUX4. Does not cross react with DUX4c.

Immunogen

C-terminal 76 amino acids of DUX4 with glutathione-s-transferase (GST) tag

Leistungsmerkmale und Vorteile

Evaluate our antibodies with complete peace of mind. If the antibody does not perform in your application, we will issue a full credit or replacement antibody. Learn more.

Physikalische Form

Solution in PBS, pH 7.4, 50% glycerol, and 0.09% sodium azide

Haftungsausschluss

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Sicherheitshinweise

• Lagerklassenschlüssel: 10 - Combustible liquids
• WGK: WGK 1
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable